Nisa Investment Advisors Portfolio holdings
AUM
$22.2B
1-Year Return
21.03%
This Quarter Return
+21.72%
1 Year Return
+21.03%
3 Year Return
+95.61%
5 Year Return
+159.15%
10 Year Return
+382.87%
AUM
$10.9B
AUM Growth
+$1.89B
(+21%)
Cap. Flow
+$185M
Cap. Flow
% of AUM
1.7%
Top 10 Holdings %
Top 10 Hldgs %
21.79%
Holding
2,159
New
88
Increased
945
Reduced
633
Closed
96
Top Buys
| 1 |
Apple
AAPL
|
$16.9M |
| 2 |
Meta Platforms (Facebook)
META
|
$15M |
| 3 |
Amazon
AMZN
|
$12.2M |
| 4 |
AbbVie
ABBV
|
$12M |
| 5 |
American Tower
AMT
|
$9.94M |
Top Sells
| 1 |
AGN
Allergan plc
AGN
|
$18.9M |
| 2 |
RTN
Raytheon Company
RTN
|
$12.4M |
| 3 |
Chubb
CB
|
$6.08M |
| 4 |
Microsoft
MSFT
|
$5.97M |
| 5 |
Procter & Gamble
PG
|
$5.32M |
Sector Composition
| 1 | Technology | 22.29% |
| 2 | Healthcare | 15.34% |
| 3 | Financials | 12.17% |
| 4 | Consumer Discretionary | 8.84% |
| 5 | Communication Services | 8.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1626
Atlanta Braves Holdings Series B
BATRK
$2.66B
| $40K | ﹤0.01% |
2,005
-105
| -5% | -$2.1K |
|
1627
Fossil Group
FOSL
$160M
| $40K | ﹤0.01% |
8,700
-5,060
| -37% | -$23.3K |
|
1628
NewMarket
NEU
$7.8B
| $40K | ﹤0.01% |
100
-180
| -64% | -$72K |
|
1629
Travere Therapeutics
TVTX
$1.89B
| $40K | ﹤0.01% |
1,970
| – | – |
|
1630
Axon Enterprise
AXON
$58.2B
| $39K | ﹤0.01% |
395
-25
| -6% | -$2.47K |
|
1631
BJs Wholesale Club
BJ
$13B
| $39K | ﹤0.01% |
+1,055
| New | +$39K |
|
1632
Sanmina
SANM
$6.42B
| $39K | ﹤0.01% |
1,540
+130
| +9% | +$3.29K |
|
|
ATSG
1633
DELISTED
Air Transport Services Group, Inc.
ATSG
| $39K | ﹤0.01% |
1,760
+170
| +11% | +$3.77K |
|
|
WPG
1634
DELISTED
Washington Prime Group Inc.
WPG
| $39K | ﹤0.01% |
5,211
-203
| -4% | -$1.52K |
|
|
BHVN
1635
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $39K | ﹤0.01% |
540
-520
| -49% | -$37.6K |
|
1636
Essent Group
ESNT
$6.28B
| $38K | ﹤0.01% |
1,045
+315
| +43% | +$11.5K |
|
1637
Fidelity D&D Bancorp
FDBC
$252M
| $38K | ﹤0.01% |
785
+505
| +180% | +$24.4K |
|
1638
Hamilton Lane
HLNE
$6.48B
| $38K | ﹤0.01% |
560
+170
| +44% | +$11.5K |
|
1639
HealthEquity
HQY
$7.95B
| $38K | ﹤0.01% |
645
-255
| -28% | -$15K |
|
1640
Novanta
NOVT
$4.13B
| $38K | ﹤0.01% |
355
+45
| +15% | +$4.82K |
|
1641
Novavax
NVAX
$1.25B
| $38K | ﹤0.01% |
455
+75
| +20% | +$6.26K |
|
1642
Dana Inc
DAN
$2.72B
| $37K | ﹤0.01% |
3,020
-1,260
| -29% | -$15.4K |
|
1643
Lattice Semiconductor
LSCC
$9.05B
| $37K | ﹤0.01% |
1,290
-50
| -4% | -$1.43K |
|
|
AAIC
1644
DELISTED
Arlington Asset Investment Corp.
AAIC
| $37K | ﹤0.01% |
12,476
+3,278
| +36% | +$9.72K |
|
|
ENDP
1645
DELISTED
Endo International plc
ENDP
| $37K | ﹤0.01% |
10,750
-18,466
| -63% | -$63.6K |
|
|
BPMC
1646
DELISTED
Blueprint Medicines
BPMC
| $36K | ﹤0.01% |
460
+90
| +24% | +$7.04K |
|
1647
Heidrick & Struggles
HSII
$1.03B
| $36K | ﹤0.01% |
1,670
-210
| -11% | -$4.53K |
|
1648
Xencor
XNCR
$595M
| $36K | ﹤0.01% |
1,120
+710
| +173% | +$22.8K |
|
|
NVRO
1649
DELISTED
NEVRO CORP.
NVRO
| $36K | ﹤0.01% |
300
+40
| +15% | +$4.8K |
|
|
PEI
1650
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
| $36K | ﹤0.01% |
1,760
+463
| +36% | +$9.47K |
|